S-892216

DRUG2 trials

Sponsors

Shionogi

Conditions

COVID-19

Phase 1

A Drug-drug Interaction Study of S-892216 Coadministered With Carbamazepime to Healthy Adult Participants

CompletedNCT06751017

ShionogiCOVID-19

Start: 2024-12-17End: 2025-02-24Updated: 2025-03-11

Phase 2

A Study of S-892216 in Participants With COVID-19

CompletedNCT06928051

ShionogiCOVID-19

Start: 2025-06-06End: 2025-09-22Updated: 2025-09-30